Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

28 results about "Norcantharidin" patented technology

Norcantharidin is a synthetic anticancer compound.

Adriamycin-tetravalent platinum drug-norcantharidin three-drug combined nano-drug as well as preparation method and application thereof

The invention discloses an adriamycin-tetravalent platinum drug-norcantharidin three-drug combined nano-drug as well as a preparation method and application thereof, and belongs to the technical field of medical materials. A tetravalent platinum drug modified by demethylated cantharidin and adriamycin are used as raw materials, a novel nano-drug is constructed through Cu < 2 + > coordination, and then the nano-drug combining adriamycin, the tetravalent platinum drug and demethylated cantharidin is prepared by polymerizing polydopamine with a mild photo-thermal effect. The polymer has the capacity of controllably releasing drugs under acidity and reduction, can realize photo-thermal conversion under laser irradiation to generate a mild photo-thermal effect, has a better tumor cell killing effect, has the capacity of consuming glutathione and generating hydroxyl radicals, can enter cancer cells in an endocytosis mode and release DOX, and can be used for killing tumor cells. And a new thought is provided for multi-drug combination and chemotherapy-chemokinetics therapy-photothermal therapy multi-mode combined therapy.
Owner:QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES)

Norcantharidin derivative as well as preparation method and application thereof

The invention discloses a norcantharidin derivative as well as a preparation method and application thereof, and belongs to the field of organic synthesis. Chiral modification is performed on the oxygen ring on the left side, so that the bactericidal performance of the derivative is improved. Experiments show that part of the series of norcantharidin derivatives have better bactericidal activity on sclerotinia sclerotiorum and botrytis cinerea, and the activity is remarkably improved compared with that of parent norcantharidin, so that the norcantharidin derivatives are expected to be used for preparing efficient, environment-friendly and low-toxicity bactericides.
Owner:UNIV OF SCI & TECH OF CHINA

Preparation of copper ion mediated glycyrrhizic acid and norcantharidin ternary carrier-free co-assembled injectable hydrogel and anti-tumor application of copper ion mediated glycyrrhizic acid and norcantharidin ternary carrier-free co-assembled injectable hydrogel

The invention discloses preparation and application of a ternary carrier-free injectable hydrogel formed by co-assembling glycyrrhizic acid, norcantharidin and metal copper ions. The hydrogel can form gel under the condition of not adding auxiliary materials, has excellent gel material properties such as injectability, heat sensitivity and stability, and can be used as an ideal anti-tumor drug to be clinically applied. The hydrogel has the effects of inducing tumor cell apoptosis and copper death and resisting inflammation, and cooperatively regulates and controls a tumor microenvironment; and laser irradiation is combined to assist in enhancing the Fenton-like effect, so that chemical kinetic treatment of tumors is realized. In a Hepa1-6 tumor-bearing liver cancer mouse model, the hydrogel has an excellent anti-tumor effect, and the drug effect is obviously superior to that of each monomer drug group. In addition, the hydrogel has good biocompatibility, and is a novel anti-tumor hydrogel which is simple to prepare, green and has clinical transformation potential.
Owner:BEIJING UNIV OF CHINESE MEDICINE

Engineering lactobacillus paracasei extracellular vesicle entrapped norcantharidin nanoparticle and application thereof

PendingCN121796627AEnhance anti-colorectal cancer efficacyinhibit metastasis effectDigestive systemPharmaceutical non-active ingredientsBacterial extracellular vesicleTumor chemotherapy
The invention belongs to the field of biological medicine, and particularly discloses a method for preparing nanoparticles NCTD-LpEV-cRGD by adopting bacterial extracellular vesicles (LpEV) derived from lactobacillus paracasei to entrap tumor chemotherapeutic drug norcantharidin (NCTD) and modifying tumor targeting peptide cRGD on the surface of the LpEV. An anti-colorectal cancer effect test research shows that the NCTD-coated LpEV-cRGD nanoparticle can simultaneously exert a colorectal cancer cell targeting effect and an anti-colorectal cancer proliferation and metastasis effect, so that the anti-colorectal metastasis curative effects of chemotherapeutic drugs norcantharidin and bacterial extracellular vesicles are remarkably enhanced, and the NCTD-coated LpEV-cRGD nanoparticle has good safety. The NCTD-coated LpEV-cRGD nanoparticles prepared by the preparation method disclosed by the invention can be used for preparing medicines for resisting colorectal metastasis.
Owner:SHANGHAI PUTUO DISTRICT CENT HOSPITAL